Middle East Healthcare Company
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Middle East Healthcare Company's yearly results (2022–2025), compared with Healthcare companies in Saudi Arabia. Tap ? on any ratio for what it means.
What stands out
- Profit Cash Ratio: Over the last 3 years, every SAR 100 of reported profit came with SAR 250 of operating cash. Higher than 96% of Healthcare companies in Saudi Arabia.
- Cash Cushion Ratio: Debt, after subtracting cash, is 1.2 times its market value (net debt). Lower than 96% of Healthcare companies in Saudi Arabia.
Where SAR 100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
SAR 250Over the last 3 years, every SAR 100 of reported profit came with SAR 250 of operating cash.
Higher than 96% of Healthcare companies in Saudi Arabia.
Self-Funding Ratio
1.3×Over the last 3 years its own operating cash covered its investment spending (capex) 1.3 times.
Lower than 79% of Healthcare companies in Saudi Arabia.
Cash Locked Ratio
SAR 56For every SAR 100 of sales, SAR 56 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against SAR 63 tied up three years earlier.
More money tied up than 79% of Healthcare companies in Saudi Arabia.
Growth quality
Steadiness Ratio
3/3 · 2/3Sales grew in 3 of the last 3 years; profit grew in 2 of 3.
Less steady than 67% of Healthcare companies in Saudi Arabia.
Growth Efficiency Ratio
SAR 24Sales grew 44% in 3 years; of every extra SAR 100 of sales, SAR 24 became extra profit.
Higher than 71% of Healthcare companies in Saudi Arabia.
Asset Productivity Ratio
+44% / +21%In 3 years sales changed by +44% while total assets changed by +21%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
0.7×Debt due within a year is covered 0.7 times by its yearly operating cash.
Lower than 79% of Healthcare companies in Saudi Arabia.
Cash Cushion Ratio
1.2× debtDebt, after subtracting cash, is 1.2 times its market value (net debt).
Lower than 96% of Healthcare companies in Saudi Arabia.
Tangible Assets Ratio
99%Of every SAR 100 the company owns, SAR 99 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 59% of Healthcare companies in Saudi Arabia.
Tangible Net Worth Ratio
97%Of every SAR 100 of net worth, SAR 97 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 59% of Healthcare companies in Saudi Arabia.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Middle East Healthcare Company owes SAR 0.69 for every SAR 1 it owns. Net profit rose 7% in the year to Dec 2025, and grew 59% a year on average over 3 years.
Compared with Healthcare companies in Saudi Arabia · latest annual results Dec 2025.
P/E ratio
14.6Investors pay SAR 14.6 for every SAR 1 of Middle East Healthcare Company's yearly profit, lower than 54% of Healthcare companies in Saudi Arabia.
P/B ratio
1.38The share price is 1.38 times Middle East Healthcare Company's book value per share, lower than 96% of Healthcare companies in Saudi Arabia.
Market cap
SAR 2.1 BThe total market value of all of Middle East Healthcare Company's shares at today's price (share price × number of shares), smaller than 88% of Healthcare companies in Saudi Arabia. PosiCap size class: Mini Cap.
Net worth (book value)
SAR 1.5 BWhat Middle East Healthcare Company would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
SAR 16.76Net worth divided by the number of shares. The share price of SAR 23.15 is 1.4 times this, which is the P/B above.
Owes vs Owns
0.69×Middle East Healthcare Company owes SAR 0.69 for every SAR 1 it owns (moderate), higher than 88% of Healthcare companies in Saudi Arabia.
Dividend yield
2.24%Middle East Healthcare Company pays 2.24% of its share price as dividends a year, lower than 79% of dividend-paying Healthcare companies in Saudi Arabia.
Revenue growth
+8%Revenue rose 8% in the year to Dec 2025, and grew 13% a year on average over 3 years.
Profit growth
+7%Net profit rose 7% in the year to Dec 2025, and grew 59% a year on average over 3 years.
Profit margin
9.7%Middle East Healthcare Company keeps SAR 10 of every SAR 100 of revenue as net profit.
Cash quality
1.8×Cash from Middle East Healthcare Company's business was 1.8× its reported profit in the year to Dec 2025 — its profit turned into cash.
Interest cover
2.0×Middle East Healthcare Company's operating profit covered its interest costs 2.0 times in the year to Dec 2025.
Cash vs debt
Net debtMiddle East Healthcare Company had SAR 2.5 B more debt than cash (net debt) at Dec 2025.
Questions
What is Middle East Healthcare Company's P/E ratio?
Investors pay SAR 14.6 for every SAR 1 of Middle East Healthcare Company's yearly profit, lower than 54% of Healthcare companies in Saudi Arabia.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Middle East Healthcare Company: SAR 2.1 B ÷ SAR 1.5 B (30 Jun 2026) = 1.4.
How much does Middle East Healthcare Company owe compared with what it owns?
Middle East Healthcare Company owes SAR 0.69 for every SAR 1 it owns (moderate), higher than 88% of Healthcare companies in Saudi Arabia.
Does Middle East Healthcare Company pay a dividend?
Yes. Middle East Healthcare Company pays 2.24% of its share price as dividends a year, lower than 79% of dividend-paying Healthcare companies in Saudi Arabia.
Is Middle East Healthcare Company's revenue growing?
Revenue rose 8% in the year to Dec 2025, and grew 13% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.